Konturek S J, Brzozowski T, Piastucki I, Radecki T, Dembińska-Kieć A
Dig Dis Sci. 1983 Feb;28(2):154-60. doi: 10.1007/BF01315145.
The effects of a new selective inhibitor of thromboxane biosynthesis, OKY-1581, and a potent inhibitor of cyclooxygenase, indomethacin, on gastric mucosal lesions induced by taurocholate or ethanol and mucosal generation of prostaglandins have been studied in rats. OKY-1581 prevented, dose dependently, the formation of taurocholate- but not ethanol-induced gastric necrosis, and this effect was accompanied by an increase in gastric mucosal generation of prostaglandin E2 and I2-like activity and a reduction in the thromboxane generation during platelet aggregation. OKY-1581 enhanced the cytoprotective action of "mild" irritants such as 5 mM taurocholate against gastric damage by 100 mM taurocholate, whereas indomethacin produced opposite effects. This study indicates: (1) the inhibition of thromboxane biosynthesis results in increased generation of prostaglandins which seems to contribute to the gastric mucosal integrity and, (2) thromboxanes may be involved in the pathogenesis of taurocholate-induced gastric mucosal lesions.
在大鼠中研究了新型血栓素生物合成选择性抑制剂OKY - 1581和强效环氧化酶抑制剂吲哚美辛对牛磺胆酸盐或乙醇诱导的胃黏膜损伤以及黏膜前列腺素生成的影响。OKY - 1581剂量依赖性地预防了牛磺胆酸盐诱导的胃坏死形成,但对乙醇诱导的胃坏死无效,且该作用伴随着胃黏膜前列腺素E2生成增加以及类似I2的活性增加,同时血小板聚集过程中血栓素生成减少。OKY - 1581增强了“轻度”刺激物如5 mM牛磺胆酸盐对100 mM牛磺胆酸盐所致胃损伤的细胞保护作用,而吲哚美辛则产生相反作用。本研究表明:(1)血栓素生物合成的抑制导致前列腺素生成增加,这似乎有助于维持胃黏膜完整性;(2)血栓素可能参与牛磺胆酸盐诱导的胃黏膜损伤的发病机制。